首页> 外文期刊>Peptides: An International Journal >NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.
【24h】

NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.

机译:NPY Y2受体激动剂PYY(3-36)通过减少小鼠肠液分泌和减缓结肠运输来抑制腹泻。

获取原文
获取原文并翻译 | 示例
       

摘要

Peptide YY (PYY)(3-36), a neuropeptide Y (NPY) Y2 receptor agonist, is a powerful inhibitor of intestinal secretion. Based on this anti-secretory effect, NPY Y2 receptor agonists may be useful as novel anti-diarrheal agents, but anti-diarrheal efficacy has yet to be determined. We therefore examined the anti-diarrheal efficacy of PYY(3-36) and a selective Y2 receptor agonist, N-acetyl-[Leu28, Leu31]-NPY(24-36), in experimental mouse models of diarrhea. Intraperitoneal administration of PYY(3-36) (0.01-1mg/kg) and N-acetyl-[Leu28, Leu31]-NPY(24-36) (10mg/kg) significantly inhibited diarrhea (increase in wet fecal weight and diarrhea score) induced by dimethyl-prostaglandin E2, 5-hydroxytryptamine, and castor oil. Anti-diarrheal activities of PYY(3-36) and N-acetyl-[Leu28, Leu31]-NPY(24-36) were comparable to the effects of loperamide (1mg/kg), a widely used anti-diarrheal drug. To clarify the anti-diarrheal mechanisms of NPY Y2 receptor agonists, we investigated the effects of PYY(3-36) and N-acetyl-[Leu28, Leu31]-NPY(24-36) on intestinal fluid secretion and colonic transit. PYY(3-36) (1mg/kg) and N-acetyl-[Leu28, Leu31]-NPY(24-36) (10mg/kg) significantly reduced dimethyl-prostaglandin E2-induced intestinal fluid accumulation in conscious mice, suggesting that NPY Y2 receptor agonists inhibit diarrhea, at least in part, by reducing intestinal secretion. In addition, PYY(3-36) (0.01-1mg/kg) and N-acetyl-[Leu28, Leu31]-NPY(24-36) (10mg/kg) potently inhibited normal fecal output, suggesting that NPY Y2 receptor activation inhibits colonic motor function and NPY Y2 receptor agonists inhibit diarrhea partly by slowing colonic transit. These results indicate that NPY Y2 receptor agonists inhibit diarrhea in mice by not only reducing intestinal fluid secretion, but also slowing colonic transit, and illustrate the therapeutic potential of NPY Y2 receptor agonists as effective treatments for diarrhea.
机译:肽YY(PYY)(3-36)是一种神经肽Y(NPY)Y2受体激动剂,是一种强大的肠道分泌抑制剂。基于这种抗分泌作用,NPY Y2受体激动剂可以用作新型抗腹泻剂,但是抗腹泻功效尚未确定。因此,我们在实验性腹泻小鼠模型中检查了PYY(3-36)和选择性Y2受体激动剂N-乙酰基-[Leu28,Leu31] -NPY(24-36)的抗腹泻功效。腹膜内施用PYY(3-36)(0.01-1mg / kg)和N-乙酰基-[Leu28,Leu31] -NPY(24-36)(10mg / kg)可以显着抑制腹泻(增加粪便湿重和腹泻评分) )由二甲基前列腺素E2、5-羟基色胺和蓖麻油诱导。 PYY(3-36)和N-乙酰基-[Leu28,Leu31] -NPY(24-36)的抗腹泻活性与广泛使用的抗腹泻药洛哌丁胺(1mg / kg)的作用相当。为了阐明NPY Y2受体激动剂的抗腹泻机制,我们研究了PYY(3-36)和N-乙酰基-[Leu28,Leu31] -NPY(24-36)对肠液分泌和结肠转运的影响。在有意识的小鼠中,PYY(3-36)(1mg / kg)和N-乙酰基-[Leu28,Leu31] -NPY(24-36)(10mg / kg)显着降低了二甲基-前列腺素E2诱导的肠液积聚。 NPY Y2受体激动剂至少部分通过减少肠道分泌来抑制腹泻。此外,PYY(3-36)(0.01-1mg / kg)和N-乙酰基-[Leu28,Leu31] -NPY(24-36)(10mg / kg)有力地抑制了正常的粪便输出,表明NPY Y2受体激活抑制结肠运动功能,而NPY Y2受体激动剂部分通过减缓结肠运输来抑制腹泻。这些结果表明NPY Y2受体激动剂不仅通过减少肠液分泌,而且减慢结肠运输来抑制小鼠的腹泻,并且说明了NPY Y2受体激动剂作为腹泻的有效治疗方法的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号